Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism

Thrombosis Research

Volumn 126, Issue 4, 2010, Pages 345-349

  Garcia Rodriguez, P ^a   Eikenboom, H C J ^a   Tesselaar, M E T ^a,b   Huisman, M V ^a   Nijkeuter, M ^a   Osanto, S ^a   Bertina, R M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cancer; Microparticles; Pulmonary embolism; Thrombosis; Tissue factor

Indexed keywords

THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PLATELET MICROPARTICLE; PRIORITY JOURNAL; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL-DERIVED MICROPARTICLES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; THROMBOPLASTIN; YOUNG ADULT;

EID: 77957159317     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.07.006     Document Type: Article

References (40)

1. M.J. VanWijk, E. VanBavel, A. Sturk, and R. Nieuwland Microparticles in cardiovascular diseases Cardiovasc Res 59 2003 277 287
2. O. Morel, F. Toti, B. Hugel, B. Bakouboula, and L. Camoin-Jau gnat-George F, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26 2006 2594 2604
3. C.I. Del, L.D. Bharwani, D.J. Dietzen, U. Pendurthi, P. Thiagarajan, and J.A. Lopez Microvesicle-associated tissue factor and Trousseau's syndrome J Thromb Haemost 5 2007 70 74
4. M.E. Tesselaar, F.P. Romijn, D.L.I. Van, F.A. Prins, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 2007 520 527
5. M.E. Tesselaar, and S. Osanto Risk of venous thromboembolism in lung cancer Curr Opin Pulm Med 13 2007 362 367
6. G. Hron, M. Kollars, H. Weber, V. Sagaster, P. Quehenberger, and S. Eichinger Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer Thromb Haemost 97 2007 119 123
7. J.A. Chirinos, G.A. Heresi, H. Velasquez, W. Jy, J.J. Jimenez, and E. Ahn Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism J Am Coll Cardiol 45 2005 1467 1471
8. K.G. Mann Biochemistry and physiology of blood coagulation Thromb Haemost 82 1999 165 174
9. B. Hugel, M.C. Martinez, C. Kunzelmann, and J.M. Freyssinet Membrane microparticles: two sides of the coin Physiology (Bethesda) 20 2005 22 27
10. P.L. Giesen, U. Rauch, B. Bohrmann, D. Kling, M. Roque, and J.T. Fallon Blood-borne tissue factor: another view of thrombosis Proc Natl Acad Sci USA 96 1999 2311 2315
11. O. Morel, F. Toti, B. Hugel, and J.M. Freyssinet Cellular microparticles: a disseminated storage pool of bioactive vascular effectors Curr Opin Hematol 11 2004 156 164
12. I. Muller, A. Klocke, M. Alex, M. Kotzsch, T. Luther, and E. Morgenstern Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets FASEB J 17 2003 476 478
13. M. Davila, A. Amirkhosravi, E. Coll, H. Desai, L. Robles, and J. Colon Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation J Thromb Haemost 6 2008 1517 1524
14. G.M. Thomas, L. Panicot-Dubois, R. Lacroix, F. gnat-George, D. Lombardo, and C. Dubois Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo J Exp Med 206 2009 1913 1927
15. B. Furie, and B.C. Furie In vivo thrombus formation J Thromb Haemost 5 Suppl 1 2007 12 17
16. J. Chou, N. Mackman, G. Merrill-Skoloff, B. Pedersen, B.C. Furie, and B. Furie Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation Blood 104 2004 3190 3197
17. J. Polgar, J. Matuskova, and D.D. Wagner The P-selectin, tissue factor, coagulation triad J Thromb Haemost 3 2005 1590 1596
18. J.W. Blom, C.J. Doggen, S. Osanto, and F.R. Rosendaal Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 2005 715 722
19. N. Levitan, A. Dowlati, S.C. Remick, H.I. Tahsildar, L.D. Sivinski, and R. Beyth Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 1999 285 291
20. S. Sallah, J.Y. Wan, and N.P. Nguyen Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thromb Haemost 87 2002 575 579
21. A.K. Kakkar, M. Levine, H.M. Pinedo, R. Wolff, and J. Wong Venous thrombosis in cancer patients: insights from the FRONTLINE survey Oncologist 8 2003 381 388
22. J.W. Blom, J.P. Vanderschoot, M.J. Oostindier, S. Osanto, F.J. van der Meer, and F.R. Rosendaal Incidence of venous thrombosis in a large cohort of 66, 329 cancer patients: results of a record linkage study J Thromb Haemost 4 2006 529 535
23. H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850
24. B. Furie, and B.C. Furie Cancer-associated thrombosis Blood Cells Mol Dis 36 2006 177 181
25. D.A. Manly, J. Wang, S.L. Glover, R. Kasthuri, H.A. Liebman, and N.S. Key Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism Thromb Res 125 2010 511 512
26. M.E. Tesselaar, F.P. Romijn, D.L.I. Van, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity in cancer patients with and without thrombosis J Thromb Haemost 7 2009 1421 1423
27. A.K. Kakkar, N.R. Lemoine, M.F. Scully, S. Tebbutt, and R.C. Williamson Tissue factor expression correlates with histological grade in human pancreatic cancer Br J Surg 82 1995 1101 1104
28. A.A. Khorana, S.A. Ahrendt, C.K. Ryan, C.W. Francis, R.H. Hruban, and Y.C. Hu Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer Clin Cancer Res 13 2007 2870 2875
29. F.R. Rickles, G.A. Hair, R.A. Zeff, E. Lee, and R.D. Bona Tissue factor expression in human leukocytes and tumor cells Thromb Haemost 74 1995 391 395
30. K. Uno, S. Homma, T. Satoh, K. Nakanishi, D. Abe, and K. Matsumoto Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer Br J Cancer 96 2007 290 295
31. J.I. Zwicker, H.A. Liebman, D. Neuberg, R. Lacroix, K.A. Bauer, and B.C. Furie Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy Clin Cancer Res 15 2009 6830 6840
32. B.A. van, H.R. Buller, M.V. Huisman, P.M. Huisman, K. Kaasjager, and P.W. Kamphuisen Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography JAMA 295 2006 172 179
33. Y. Yuana, T.H. Oosterkamp, S. Bahatyrova, B. Ashcroft, R.P. Garcia, and R.M. Bertina Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles J Thromb Haemost 8 2010 315 323
34. C. Ay, J.M. Freyssinet, T. Sailer, R. Vormittag, and I. Pabinger Circulating procoagulant microparticles in patients with venous thromboembolism Thromb Res 123 2009 724 726
35. A. Smith, J.W. Quarmby, M. Collins, S.M. Lockhart, and K.G. Burnand Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis Thromb Haemost 82 1999 1593 1599
36. L.M. Vieira, L.M. Dusse, A.P. Fernandes, O.A. Martins-Filho, B.M. de, and M.F. Ferreira Monocytes and plasma tissue factor levels in normal individuals and patients with deep venous thrombosis of the lower limbs: potential diagnostic tools? Thromb Res 119 2007 157 165
37. B.A. Steppich, S.L. Braun, A. Stein, G. Demetz, P. Groha, and A. Schomig Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction Thromb J 7 2009 11
38. M. Falciani, A.M. Gori, S. Fedi, L. Chiarugi, I. Simonetti, and R.P. Dabizzi Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients Thromb Haemost 79 1998 495 499
39. V. Roldan, F. Marin, P. Fernandez, J. Lujan, J.G. Martinez, and J. Pineda Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction Int J Cardiol 78 2001 115 119
40. R.R. Bach Tissue factor encryption Arterioscler Thromb Vasc Biol 26 2006 456 461